Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Tatiana Shelekhova | Researchclopedia

Back to researchers

Tatiana Shelekhova

Saratov State Medical University

59

Works

2,570

Citations

13

h-index

15

i10-index

Research Topics

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Cancer Treatment and Pharmacology

Affiliations

Saratov Research Institute of Traumatology and Orthopedics2017–2022

Ministry of Health of the Russian Federation2023–2023

Saratov State Medical University2011–2026

Top Works

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

María‐Victoria Mateos,Meletios Α. Dimopoulos,et al.

2017971 citations

Peptidase Inhibition and Analysis

Chronic Lymphocytic Leukemia Research

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

Jesús F. San Miguel,Vânia Hungria,et al.

2014783 citations

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

María‐Victoria Mateos,Michèle Cavo,et al.

2019434 citations

Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study

Jacob P. Laubach,Fredrik Schjesvold,et al.

202067 citations

The impact of <em>ABCB1</em> (rs1045642 and rs4148738) and <em>CES1</em> (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty

Dmitriy Alekseevich Sychev,А. Н. Леванов,et al.

201850 citations

Results from a randomized phase III trial of decitabine versus supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed AML.

Xavier Thomas,Anna Dmoszyńska,et al.

201129 citations

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone

María‐Victoria Mateos,Michèle Cavo,et al.

201925 citations

Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial

Stefan Knop,María‐Victoria Mateos,et al.

202123 citations

Update on a Phase III Study of Panobinostat with Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: PANORAMA 1,

Jesús F. San Miguel,Vânia Hungria,et al.

201122 citations